Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 41Glioma 10Brain Neoplasms 9Gliosarcoma 8Astrocytoma 7Neuroblastoma 6Small Cell Lung Carcinoma 4Oligodendroglioma 4Neoplasms 4Medulloblastoma 4Sarcoma, Ewing 3Sarcoma 3Melanoma 3Somatostatinoma 2Rhabdomyosarcoma 2Recurrence 2Pheochromocytoma 2Paraganglioma 2Neuroendocrine Tumors 2Lung Neoplasms 2Ependymoma 2Diffuse Intrinsic Pontine Glioma 2Desmoplastic Small Round Cell Tumor 2Central Nervous System Neoplasms 2Carcinoma, Neuroendocrine 2Adenoma, Islet Cell 2Supratentorial Neoplasms 1Spinal Cord Neoplasms 1Rhabdoid Tumor 1Prostatic Neoplasms 1

Interventions

Gemcitabine 42130-nm albumin-bound paclitaxel 26Albumin-Bound Paclitaxel 18Irinotecan 16Oxaliplatin 14Fluorouracil 14pembrolizumab 13Nivolumab 13Magnetic Resonance Spectroscopy 11Leucovorin 11Taxes 10Specimen Handling 9Biopsy 9Cisplatin 8Capecitabine 7folfirinox 6Radiotherapy 6Carboplatin 6irinotecan sucrosofate 5durvalumab 5Ipilimumab 5Cyclophosphamide 5olaparib 4defactinib 4Surveys and Questionnaires 4Standard of Care 4Radiosurgery 4Immunoglobulin G 4Disulfides 4dehydroftorafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pancreatic Neoplasms × Temozolomide × Clear all
NCT03351296 2024-05-08

BETTER2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Active not recruiting
140 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡